Bruce Hiscock Purchases 300 Shares of Bioventix PLC (LON:BVXP) Stock

Bioventix PLC (LON:BVXPGet Free Report) insider Bruce Hiscock bought 300 shares of Bioventix stock in a transaction that occurred on Wednesday, October 30th. The stock was purchased at an average cost of GBX 3,330 ($43.19) per share, for a total transaction of £9,990 ($12,955.52).

Bioventix Price Performance

Shares of BVXP opened at GBX 3,650 ($47.33) on Friday. The stock has a market cap of £190.53 million, a PE ratio of 2,269.94 and a beta of 0.35. The firm has a fifty day moving average price of GBX 3,882.64 and a 200 day moving average price of GBX 4,180.14. Bioventix PLC has a 1-year low of GBX 2,977 ($38.61) and a 1-year high of GBX 5,100 ($66.14).

Bioventix Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th will be given a dividend of GBX 87 ($1.13) per share. This is a boost from Bioventix’s previous dividend of $68.00. The ex-dividend date is Thursday, November 7th. This represents a yield of 2.4%. Bioventix’s payout ratio is presently 9,693.25%.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Featured Stories

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.